Jersey City, NJ (PRWEB) July 16, 2009
NeTLIMS NJ, LLC, the provider of AutoLims®, a fully integrated LIS (Laboratory Information System) solution, today announced that its innovative blood bank management system, AutoFusion, has received market approval from the United States Food and Drug Administration (FDA).
AutoFusion uses state-of-the-art technology to provide blood banks, transfusion services and donor centers with the security and flexibility needed to provide quality medical care, categorize specimens, improve efficiency and reduce errors. Developed in collaboration with blood bank professionals in order to meet the high standards and requirements of the blood transfusion services work environment, the solution provides the safety features necessary to satisfy FDA, HIPAA and CFR requirements.
"The FDA market approval of AutoFusion allows Netlims to provide a complete and integrative solution to hospitals in the US as well as an excellent stand-alone solution for blood banks", remarked Gonen Ziv, COO of NeTLIMS. "The FDA approval is an additional milestone in NeTLIMS' journey to excellence."
About NeTLIMS NJ, LLC
NeTLIMS develops, markets and supports the AutoLims product suite. Since 1996, AutoLims has been powering hundreds of medium to large clinical laboratories in hospitals and commercial laboratories worldwide. NeTLIMS customers include Quest Diagnostics, top New York City hospitals, HMOs including Clalit - one of the worlds largest HMOs, and hundreds of laboratory installations, worldwide. Simply Powerful - AutoLims is lightning fast and extremely intuitive. AutoLims supports the complete needs of all types of clinical laboratories, from an individual lab to a network of laboratories. A perfect combination of cutting edge technology and unparalleled customizability and extendibility allows AutoLims to provide state of the art solutions for all disciplines inside the laboratory and for all stages of the testing process. For additional information please see: http://www.netlims.com.
# # #